British Regulator Says ‘COPCOV’ Hydroxychloroquine Trial Paused

May 27, 2020

(Reuters) – An international hydroxychloroquine trial led by the University of Oxford has been paused, Britain’s pharmaceutical regulator said on Wednesday, less than a week after the trial started, amid fresh safety concerns over the drug.  The French government on Wednesday cancelled a decree allowing hospital doctors to administer hydroxychloroquine as a treatment to patients suffering severe forms of COVID-19, the illness caused by the new coronavirus.